Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Aripiprazole in Acutely Agitated Dementia Patients
NCT00095719Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dementia comparing Aripiprazole with Placebo (2 arms). Primary endpoint: Tolerability. Started Dec 2003; status: completed.
02
Drugs
aripiprazole
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT00095719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095719.